$801 Million is the total value of JNBA Financial Advisors's 749 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGG | New | ISHARES TRcore us aggbd et | $267,826 | – | 2,848 | +100.0% | 0.03% | – |
BNDX | New | VANGUARD CHARLOTTE FDStotal int bd etf | $47,496 | – | 993 | +100.0% | 0.01% | – |
HLT | New | HILTON WORLDWIDE HLDGS INC | $15,769 | – | 105 | +100.0% | 0.00% | – |
HII | New | HUNTINGTON INGALLS INDS INC | $15,139 | – | 74 | +100.0% | 0.00% | – |
SHV | New | ISHARES TRshort treas bd | $16,571 | – | 150 | +100.0% | 0.00% | – |
CRWD | New | CROWDSTRIKE HLDGS INCcl a | $16,571 | – | 99 | +100.0% | 0.00% | – |
New | CIBUS INC | $12,062 | – | 662 | +100.0% | 0.00% | – | |
New | WISDOMTREE TRartificial intel | $17,420 | – | 1,000 | +100.0% | 0.00% | – | |
XYL | New | XYLEM INC | $13,655 | – | 150 | +100.0% | 0.00% | – |
PPL | New | PPL CORP | $7,870 | – | 334 | +100.0% | 0.00% | – |
XRAY | New | DENTSPLY SIRONA INC | $5,124 | – | 150 | +100.0% | 0.00% | – |
EMXC | New | ISHARES INCmsci emrg chn | $4,983 | – | 100 | +100.0% | 0.00% | – |
BTI | New | BRITISH AMERN TOB PLCsponsored adr | $4,712 | – | 150 | +100.0% | 0.00% | – |
EVF | New | EATON VANCE SR INCOME TRsh ben int | $7,865 | – | 1,333 | +100.0% | 0.00% | – |
SPG | New | SIMON PPTY GROUP INC NEW | $9,399 | – | 87 | +100.0% | 0.00% | – |
EFR | New | EATON VANCE SR FLTNG RTE TR | $8,066 | – | 666 | +100.0% | 0.00% | – |
SQM | New | SOCIEDAD QUIMICA Y MINERA DEspon adr ser b | $8,951 | – | 150 | +100.0% | 0.00% | – |
TM | New | TOYOTA MOTOR CORPads | $5,393 | – | 30 | +100.0% | 0.00% | – |
FMC | New | FMC CORP | $8,037 | – | 120 | +100.0% | 0.00% | – |
New | VANECK ETF TRUST | $6,370 | – | 250 | +100.0% | 0.00% | – | |
DIVO | New | AMPLIFY ETF TRcwp enhanced div | $7,169 | – | 206 | +100.0% | 0.00% | – |
VDE | New | VANGUARD WORLD FDSenergy etf | $9,886 | – | 78 | +100.0% | 0.00% | – |
MMC | New | MARSH & MCLENNAN COS INC | $5,139 | – | 27 | +100.0% | 0.00% | – |
SGEN | New | SEAGEN INC | $1,061 | – | 5 | +100.0% | 0.00% | – |
SIX | New | SIX FLAGS ENTMT CORP NEW | $1,105 | – | 47 | +100.0% | 0.00% | – |
BIOB | New | BIO RAD LABS INCcl b | $711 | – | 2 | +100.0% | 0.00% | – |
EBS | New | EMERGENT BIOSOLUTIONS INC | $1,116 | – | 328 | +100.0% | 0.00% | – |
SU | New | SUNCOR ENERGY INC NEW | $379 | – | 11 | +100.0% | 0.00% | – |
ET | New | ENERGY TRANSFER L P | $309 | – | 22 | +100.0% | 0.00% | – |
EQNR | New | EQUINOR ASAsponsored adr | $624 | – | 19 | +100.0% | 0.00% | – |
ALKS | New | ALKERMES PLC | $225 | – | 8 | +100.0% | 0.00% | – |
TDC | New | TERADATA CORP DEL | $1,801 | – | 40 | +100.0% | 0.00% | – |
ES | New | EVERSOURCE ENERGY | $408 | – | 7 | +100.0% | 0.00% | – |
IONS | New | IONIS PHARMACEUTICALS INC | $318 | – | 7 | +100.0% | 0.00% | – |
MNKD | New | MANNKIND CORP | $38 | – | 9 | +100.0% | 0.00% | – |
TFC | New | TRUIST FINL CORP | $1,202 | – | 42 | +100.0% | 0.00% | – |
MYGN | New | MYRIAD GENETICS INC | $161 | – | 10 | +100.0% | 0.00% | – |
NCR | New | NCR CORP NEW | $1,079 | – | 40 | +100.0% | 0.00% | – |
BKR | New | BAKER HUGHES COMPANYcl a | $177 | – | 5 | +100.0% | 0.00% | – |
VLO | New | VALERO ENERGY CORP | $709 | – | 5 | +100.0% | 0.00% | – |
AVNS | New | AVANOS MED INC | $21 | – | 1 | +100.0% | 0.00% | – |
APA | New | APA CORPORATION | $247 | – | 6 | +100.0% | 0.00% | – |
ICPT | New | INTERCEPT PHARMACEUTICALS IN | $56 | – | 3 | +100.0% | 0.00% | – |
FIS | New | FIDELITY NATL INFORMATION SV | $498 | – | 9 | +100.0% | 0.00% | – |
INVA | New | INNOVIVA INC | $91 | – | 7 | +100.0% | 0.00% | – |
NDAQ | New | NASDAQ INC | $2,041 | – | 42 | +100.0% | 0.00% | – |
LXRX | New | LEXICON PHARMACEUTICALS INC | $15 | – | 13 | +100.0% | 0.00% | – |
ILMN | New | ILLUMINA INC | $412 | – | 3 | +100.0% | 0.00% | – |
KDP | New | KEURIG DR PEPPER INC | $948 | – | 30 | +100.0% | 0.00% | – |
TBPH | New | THERAVANCE BIOPHARMA INC | $9 | – | 1 | +100.0% | 0.00% | – |
PAA | New | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $215 | – | 14 | +100.0% | 0.00% | – |
CLX | New | CLOROX CO DEL | $2,097 | – | 16 | +100.0% | 0.00% | – |
ALNY | New | ALNYLAM PHARMACEUTICALS INC | $709 | – | 4 | +100.0% | 0.00% | – |
New | MASTERBRAND INC | $304 | – | 25 | +100.0% | 0.00% | – | |
VRTX | New | VERTEX PHARMACEUTICALS INC | $1,044 | – | 3 | +100.0% | 0.00% | – |
PBYI | New | PUMA BIOTECHNOLOGY INC | $11 | – | 4 | +100.0% | 0.00% | – |
FBHS | New | FORTUNE BRANDS INNOVATIONS I | $1,554 | – | 25 | +100.0% | 0.00% | – |
QGEN | New | QIAGEN NV | $486 | – | 12 | +100.0% | 0.00% | – |
CNQ | New | CANADIAN NAT RES LTD | $712 | – | 11 | +100.0% | 0.00% | – |
New | WEWORK INCcl a new | $76 | – | 25 | +100.0% | 0.00% | – | |
HALO | New | HALOZYME THERAPEUTICS INC | $917 | – | 24 | +100.0% | 0.00% | – |
SRPT | New | SAREPTA THERAPEUTICS INC | $485 | – | 4 | +100.0% | 0.00% | – |
HAL | New | HALLIBURTON CO | $284 | – | 7 | +100.0% | 0.00% | – |
E | New | ENI S P Asponsored adr | $352 | – | 11 | +100.0% | 0.00% | – |
CCI | New | CROWN CASTLE INC | $921 | – | 10 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-02
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 42 | Q3 2023 | 11.3% |
VANGUARD SPECIALIZED PORTFOL | 42 | Q3 2023 | 11.0% |
VANGUARD TOTAL STOCK MARKET ET | 42 | Q3 2023 | 12.6% |
ISHARES TR | 42 | Q3 2023 | 4.8% |
VANGUARD MSCI EMERGING MARKETS | 42 | Q3 2023 | 4.6% |
VANGUARD LARGE-CAP ETF | 42 | Q3 2023 | 4.7% |
VANGUARD INTL EQUITY INDEX F | 42 | Q3 2023 | 4.1% |
ISHARES TR | 42 | Q3 2023 | 2.7% |
ISHARES TR | 42 | Q3 2023 | 1.9% |
MICROSOFT CORP. | 42 | Q3 2023 | 3.6% |
View JNBA Financial Advisors's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-08 |
13F-HR | 2023-11-02 |
13F-HR | 2023-08-03 |
13F-HR | 2023-05-02 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-07 |
13F-HR | 2022-07-22 |
13F-HR | 2022-04-29 |
13F-HR | 2022-02-03 |
13F-HR | 2021-11-10 |
View JNBA Financial Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.